Molecular Mechanisms and Potential Clinical Applications of Campylobacter jejuni Cytolethal Distending Toxin. 2016

Cheng-Kuo Lai, and Yu-An Chen, and Chun-Jung Lin, and Hwai-Jeng Lin, and Min-Chuan Kao, and Mei-Zi Huang, and Yu-Hsin Lin, and Chuan Chiang-Ni, and Chih-Jung Chen, and U-Ging Lo, and Li-Chiung Lin, and Ho Lin, and Jer-Tsong Hsieh, and Chih-Ho Lai
Department of Microbiology and Immunology, Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung UniversityTaoyuan, Taiwan; Department of Urology, University of Texas Southwestern Medical CenterDallas, TX, USA.

Cytolethal distending toxin (CDT), a genotoxin produced by Campylobacter jejuni, is composed of three subunits: CdtA, CdtB, and CdtC. CdtB is a DNase that causes DNA double-strand breaks (DSB) in the nucleus resulting in cell cycle arrest at the G2/M stage and apoptosis. CdtA and CdtC bind to cholesterol-rich microdomains on the cytoplasmic membrane, a process required for the delivery of CdtB to cells. Although a unique motif associated with cholesterol-binding activity has been identified in other pathogens, the mechanism underlying the interaction between the CdtA and CdtC subunits and membrane cholesterol remains unclear. Also, the processes of cell uptake and delivery of CdtB in host cells and the translocation of CdtB into the nucleus are only partially understood. In this review, we focus on the underlying relationship among CDT, membrane cholesterol, and the intracellular trafficking pathway as a unique mechanism for C. jejuni-induced pathogenesis. Moreover, we discuss the clinical aspects of a possible therapeutic application of CDT in cancer therapy. Understanding the molecular mechanism of CDT-host interactions may provide insights into novel strategies to control C. jejuni infection and the development of potential clinical applications of CDT.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D016123 Campylobacter jejuni A species of bacteria that resemble small tightly coiled spirals. Its organisms are known to cause abortion in sheep and fever and enteritis in man and may be associated with enteric diseases of calves, lambs, and other animals. Campylobacter fetus subsp. jejuni,Vibrio hepaticus,Vibrio jejuni
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D053903 DNA Breaks, Double-Stranded Interruptions in the sugar-phosphate backbone of DNA, across both strands adjacently. Double-Stranded DNA Breaks,Double-Strand DNA Breaks,Double-Stranded DNA Break,Break, Double-Strand DNA,Break, Double-Stranded DNA,Breaks, Double-Strand DNA,Breaks, Double-Stranded DNA,DNA Break, Double-Strand,DNA Break, Double-Stranded,DNA Breaks, Double Stranded,DNA Breaks, Double-Strand,Double Strand DNA Breaks,Double Stranded DNA Break,Double Stranded DNA Breaks,Double-Strand DNA Break
D059565 G2 Phase Cell Cycle Checkpoints CELL CYCLE regulatory signaling systems that are triggered by DNA DAMAGE or lack of nutrients during G2 PHASE. When triggered they restrain cells transitioning from G2 phase to M PHASE. Antephase Checkpoint,G2 Cell Cycle Arrest,G2 Cell Cycle Checkpoints,G2 Cell Cycle Control,G2 Phase Checkpoints,G2 Restriction Point,G2-M Cell Cycle Checkpoint,Antephase Checkpoints,Checkpoint, Antephase,Checkpoint, G2 Phase,Checkpoints, Antephase,Checkpoints, G2 Phase,G2 M Cell Cycle Checkpoint,G2 Phase Checkpoint,G2 Restriction Points,Restriction Point, G2,Restriction Points, G2
D021581 Active Transport, Cell Nucleus Gated transport mechanisms by which proteins or RNA are moved across the NUCLEAR MEMBRANE. Nuclear Export,Nuclear Import,Nuclear Transport,Nucleocytoplasmic Transport,Nucleo-cytoplasmic Transport,Export, Nuclear,Import, Nuclear,Nucleo cytoplasmic Transport,Transport, Nuclear,Transport, Nucleo-cytoplasmic,Transport, Nucleocytoplasmic,Transports, Nucleo-cytoplasmic

Related Publications

Cheng-Kuo Lai, and Yu-An Chen, and Chun-Jung Lin, and Hwai-Jeng Lin, and Min-Chuan Kao, and Mei-Zi Huang, and Yu-Hsin Lin, and Chuan Chiang-Ni, and Chih-Jung Chen, and U-Ging Lo, and Li-Chiung Lin, and Ho Lin, and Jer-Tsong Hsieh, and Chih-Ho Lai
May 2000, Journal of medical microbiology,
Cheng-Kuo Lai, and Yu-An Chen, and Chun-Jung Lin, and Hwai-Jeng Lin, and Min-Chuan Kao, and Mei-Zi Huang, and Yu-Hsin Lin, and Chuan Chiang-Ni, and Chih-Jung Chen, and U-Ging Lo, and Li-Chiung Lin, and Ho Lin, and Jer-Tsong Hsieh, and Chih-Ho Lai
March 2011, Avian diseases,
Cheng-Kuo Lai, and Yu-An Chen, and Chun-Jung Lin, and Hwai-Jeng Lin, and Min-Chuan Kao, and Mei-Zi Huang, and Yu-Hsin Lin, and Chuan Chiang-Ni, and Chih-Jung Chen, and U-Ging Lo, and Li-Chiung Lin, and Ho Lin, and Jer-Tsong Hsieh, and Chih-Ho Lai
January 2015, Future microbiology,
Cheng-Kuo Lai, and Yu-An Chen, and Chun-Jung Lin, and Hwai-Jeng Lin, and Min-Chuan Kao, and Mei-Zi Huang, and Yu-Hsin Lin, and Chuan Chiang-Ni, and Chih-Jung Chen, and U-Ging Lo, and Li-Chiung Lin, and Ho Lin, and Jer-Tsong Hsieh, and Chih-Ho Lai
February 2019, Gut,
Cheng-Kuo Lai, and Yu-An Chen, and Chun-Jung Lin, and Hwai-Jeng Lin, and Min-Chuan Kao, and Mei-Zi Huang, and Yu-Hsin Lin, and Chuan Chiang-Ni, and Chih-Jung Chen, and U-Ging Lo, and Li-Chiung Lin, and Ho Lin, and Jer-Tsong Hsieh, and Chih-Ho Lai
September 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Cheng-Kuo Lai, and Yu-An Chen, and Chun-Jung Lin, and Hwai-Jeng Lin, and Min-Chuan Kao, and Mei-Zi Huang, and Yu-Hsin Lin, and Chuan Chiang-Ni, and Chih-Jung Chen, and U-Ging Lo, and Li-Chiung Lin, and Ho Lin, and Jer-Tsong Hsieh, and Chih-Ho Lai
October 2016, Jundishapur journal of microbiology,
Cheng-Kuo Lai, and Yu-An Chen, and Chun-Jung Lin, and Hwai-Jeng Lin, and Min-Chuan Kao, and Mei-Zi Huang, and Yu-Hsin Lin, and Chuan Chiang-Ni, and Chih-Jung Chen, and U-Ging Lo, and Li-Chiung Lin, and Ho Lin, and Jer-Tsong Hsieh, and Chih-Ho Lai
May 1998, Infection and immunity,
Cheng-Kuo Lai, and Yu-An Chen, and Chun-Jung Lin, and Hwai-Jeng Lin, and Min-Chuan Kao, and Mei-Zi Huang, and Yu-Hsin Lin, and Chuan Chiang-Ni, and Chih-Jung Chen, and U-Ging Lo, and Li-Chiung Lin, and Ho Lin, and Jer-Tsong Hsieh, and Chih-Ho Lai
June 2011, Veterinary microbiology,
Cheng-Kuo Lai, and Yu-An Chen, and Chun-Jung Lin, and Hwai-Jeng Lin, and Min-Chuan Kao, and Mei-Zi Huang, and Yu-Hsin Lin, and Chuan Chiang-Ni, and Chih-Jung Chen, and U-Ging Lo, and Li-Chiung Lin, and Ho Lin, and Jer-Tsong Hsieh, and Chih-Ho Lai
June 1996, Infection and immunity,
Cheng-Kuo Lai, and Yu-An Chen, and Chun-Jung Lin, and Hwai-Jeng Lin, and Min-Chuan Kao, and Mei-Zi Huang, and Yu-Hsin Lin, and Chuan Chiang-Ni, and Chih-Jung Chen, and U-Ging Lo, and Li-Chiung Lin, and Ho Lin, and Jer-Tsong Hsieh, and Chih-Ho Lai
October 2009, BMC microbiology,
Copied contents to your clipboard!